GSA Capital Partners’s Unity Biotechnology UBX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-63,994
| Closed | -$361K | – | 1874 |
|
|
2022
Q2 | $361K | Sell |
63,994
-8,426
| -12% | -$47.5K | 0.05% | 708 |
|
|
2022
Q1 | $811K | Buy |
72,420
+2,808
| +4% | +$31.4K | 0.11% | 268 |
|
|
2021
Q4 | $1.02M | Buy |
69,612
+22,875
| +49% | +$334K | 0.13% | 196 |
|
|
2021
Q3 | $1.4M | Buy |
46,737
+26,149
| +127% | +$784K | 0.14% | 154 |
|
|
2021
Q2 | $955K | Buy |
+20,588
| New | +$955K | 0.11% | 276 |
|
|
2020
Q4 | – | Sell |
-3,044
| Closed | -$105K | – | 1612 |
|
|
2020
Q3 | $105K | Buy |
+3,044
| New | +$105K | 0.02% | 1130 |
|